Signal Transduct Target Ther
Sanyal and colleagues reported the MASLD Phase 2a in Nature Medicine documenting hepatic steatosis reduction (PMID 38858523)
in 1984 of leptin (45), a peripheral active appetite inhibiting hormone produced by adipocytes and acting both via specific receptor (Ob-R) on afferent vagal nerves and directly on ARC neurons enhancing satiety, raised a hope in progress in obesity therapy (44)
Physiology of the Gastrointestinal Tract
Aronne, MD, FACP is a world-renowned physician, researcher, professor, and leading expert in weight management and GLP-1 medications
Unlike the well-known GLP-1 receptor agonists weve been talking about, who've been the leading weight loss stars for years, Mounjaro is set to steal the limelight with its dual action